Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study

M.M. de Jonge, C.D. de Kroon*, D.J. Jenner, J. Oosting, J.A. de Hullu, M.J.E. Mourits, E.B.G. Garcia, M.G.E.M. Ausems, J.M. Collee, K. van Engelen, I. van de Beek, H. Group, V.T.H.B.M. Smit, M.A. Rookus, G.H. de Bock, F.E. van Leeuwen, T. Bosse, O.M. Dekkers, C.J. van Asperen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Web of Science)
Original languageEnglish
Article numberdjab036
Pages (from-to)1203-1211
Number of pages9
JournalJournal of the National Cancer Institute
Volume113
Issue number9
DOIs
Publication statusPublished - 1 Sep 2021

Keywords

  • CLEAR-CELL
  • BODY-MASS
  • METAANALYSIS
  • TAMOXIFEN
  • THERAPY
  • INDEX

Cite this